Boston

Robotic prostatectomy
Health

Long-term study shows most prostate cancer patients don’t need aggressive treatment

By Karen Weintraub

Voice Mental Illness
Business

Tech companies enter the business of campus mental health care

By Deirdre Fernandes — Boston Globe

Best Biotech CEOs 2017
Adam's Take

Introducing the nominees for best biopharma CEO of 2018. Vote for your favorite!

By Adam Feuerstein

Cambridgeport
Exclusive

New documents shed light on secretive ElevateBio, next step for former Alexion execs

By Kate Sheridan

Biotech

Moderna’s record-setting IPO dives in its debut

By Damian Garde

Four mini-pig piglets stand around
Health

A nonprofit biotech venture is betting on pig skin to help burn victims with first-ever clinical trial

By Kate Sheridan

Family & doctor communication
Hospitals

A new way to curb harmful medical errors: talk more to patients and families

By Megan Thielking

NHS
Pharmalot

Will Vertex finally reach a deal with the U.K. over its cystic fibrosis drug?

By Ed Silverman

Biotech

Four big questions ahead of Moderna’s public debut — biotech’s biggest ever

By Damian Garde

Foundation Medicine
Biotech

For one cancer patient, biotech’s genetic test turns out to be a ‘lifesaver’

By Jonathan Saltzman — Boston Globe

Biotech

Bluebird’s gene therapy improved outcomes for patients, as push for filing gains steam

By Adam Feuerstein

Ovarian Tumor
Biotech

GSK buys cancer biotech Tesaro for $5.1B

By Adam Feuerstein

Biotech

The benefit of a blood disease drug from Acceleron and Celgene debated by experts

By Adam Feuerstein

Dr. Erica Esrick and Manny Jones
Biotech

Novel gene therapy ‘switch’ for sickle cell disease shows encouraging results in pilot trial

By Adam Feuerstein

Biotech

FDA signs off on Editas CRISPR study on patients with a rare genetic disorder

By Damian Garde

MassNextGen
Biotech

Almost no venture capital funding goes to women. Can a pitchfest bring parity to biotech?

By Kate Sheridan

Vertex
Biotech

Vertex cystic fibrosis drug combination shows strong results in pivotal clinical trials

By Adam Feuerstein

Hospital computers
Health

Doctors want ‘big data’ insights to improve health care. But America’s scattershot medical records make it hard to go big

By Kate Sheridan

Dr. Ailis Tweed Kent
Business

These three doctors are going the startup route early in their careers

By Jonathan Saltzman — Boston Globe

Adam's Take

Ziopharm shares are moving higher on a turnaround strategy, but is it for real? A closer look

By Adam Feuerstein

Aveo Pharmaceuticals
Biotech

Jury finds former Aveo CFO misled investors about kidney cancer drug

By Jonathan Saltzman — Boston Globe

Alexander Karp
Pharma

Palantir and Merck KGaA form venture to mine health care data

By Jonathan Saltzman — Boston Globe

Human sperm
In the Lab

Scientists are trying to create a contraceptive that stops sperm in its tracks

By Megan Thielking

SQZ Biotech GIF
Biotech

SQZ Biotech pushes forward with its method to squeeze drugs into cells

By Kate Sheridan

Brain neurons
Biotech

A pharma veteran best known for biotech reflects on leading a startup, pricing a drug, and investing in politics

By Adam Feuerstein, Damian Garde, and Rebecca Robbins

Nick Leschly - Bluebird Bio
Health

As new therapies arrive, pressure builds on the health care system to figure out how to pay for them

By Andrew Joseph

Pill stomach
Biotech

Sick of a daily pill? A Boston biotech wants to make a daily Alzheimer’s drug last for a week — and they’re working on more

By Kate Sheridan

STAT SPOTLIGHT
Biotech

Startup Spotlight: This biotech is attracting attention, even without a broad portfolio

By Kate Sheridan

Colorful DNA molecule
Biotech

Offering free DNA sequencing, Nebula Genomics opens for business. But there’s an itsy-bitsy catch

By Sharon Begley

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy